Preparation and characterization of polymeric and lipid nanoparticles of pilocarpine HCl for ocular application

References

• Hamidi M, Azadi A, Rafiei P. Hydrogel nanoparticles in drug delivery. Adv Drug Deliv Rev 2008;60:1638–1649.
   PubMed Web of Science ®Google Scholar
• Sahoo SK, Dilnawaz F, Krishnakumar S. Nanotechnology in ocular drug delivery. Drug Discov Today 2008;13:144–151.
   PubMed Web of Science ®Google Scholar
• Gómez-Gaete C, Tsapis N, Besnard M, Bochot A, Fattal E. Encapsulation of dexamethasone into biodegradable polymeric nanoparticles. Int J Pharm 2007;331:153–159.
   PubMed Web of Science ®Google Scholar
• Thassu D, Deleers M, Pathak Y. (ed.) Nanoparticulate drug delivery systems. Thassu D, Pathak Y, Deleers M. Nanoparticulate drug-deliver systems: an overview. drugs and the pharmaceutical sciences. vol.166, USA:Informa Healthcare, 2007:1–31.
   Google Scholar
• Torchilin, VP (ed.) Nanoparticulates as drug carriers. torchilin v. introduction. nanocarriers for drug delivery: needs and requirements. London: Imperial College Press, 2006:1–8.
   Google Scholar
• Li X, Nie SF, Kong J, Li N, Ju CY, Pan WS. A controlled-release ocular delivery system for ibuprofen based on nanostructured lipid carriers. Int J Pharm 2008;363:177–182.
   PubMed Web of Science ®Google Scholar
• Nagarwal RC, Kant S, Singh PN, Maiti P, Pandit JK. Polymeric nanoparticulate system: a potential approach for ocular drug delivery. J Control Release 2009;136:2–13.
   PubMed Web of Science ®Google Scholar
• Diebold Y, Jarrín M, Sáez V, Carvalho EL, Orea M, Calonge M et al. Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP). Biomaterials 2007;28:1553–1564.
   PubMed Web of Science ®Google Scholar
• Kapoor Y, Chauhan A. Ophthalmic delivery of Cyclosporine A from Brij-97 microemulsion and surfactant-laden p-HEMA hydrogels. Int J Pharm 2008;361:222–229.
   PubMed Web of Science ®Google Scholar
• Zurowska-Pryczkowska K, Sznitowska M, Janicki S. Studies on the effect of pilocarpine incorporation into a submicron emulsion on the stability of the drug and the vehicle. Eur J Pharm Biopharm 1999;47:255–260.
   PubMed Web of Science ®Google Scholar
• Miyazaki S, Suzuki S, Kawasaki N, Endo K, Takahashi A, Attwood D. In situ gelling xyloglucan formulations for sustained release ocular delivery of pilocarpine hydrochloride. Int J Pharm 2001;229:29–36.
   PubMed Web of Science ®Google Scholar
• Prow TW, Bhutto I, Kim SY, Grebe R, Merges C, McLeod DS et al. Ocular nanoparticle toxicity and transfection of the retina and retinal pigment epithelium. Nanomedicine 2008;4:340–349.
   PubMed Web of Science ®Google Scholar
• Budai L, Hajdú M, Budai M, Gróf P, Béni S, Noszál B et al. Gels and liposomes in optimized ocular drug delivery: studies on ciprofloxacin formulations. Int J Pharm 2007;343:34–40.
   PubMed Web of Science ®Google Scholar
• Liu Z, Zhang X, Wu H, Li J, Shu L, Liu R et al. Preparation and evaluation of solid lipid nanoparticles of baicalin for ocular drug delivery system in vitro and in vivo. Drug Dev Ind Pharm 2011;37:475–481.
   PubMed Web of Science ®Google Scholar
• Cavalli R, Gasco MR, Chetoni P, Burgalassi S, Saettone MF. Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin. Int J Pharm 2002;238:241–245.
   PubMed Web of Science ®Google Scholar
• Kalam MA, Sultana Y, Ali A, Aqil M, Mishra AK, Chuttani K. Preparation, characterization, and evaluation of gatifloxacin loaded solid lipid nanoparticles as colloidal ocular drug delivery system. J Drug Target 2010;18:191–204.
   PubMed Web of Science ®Google Scholar
• Cavalli R, Morel S, Gasco MR, Chetoni P, Saettone MF. Preparation and evaluation in vitro of colloidal liposheres containing pilocarpine as ion-pair. Int J Pharm 1995;117:243–246.
   Web of Science ®Google Scholar
• Kattan J, Droz JP, Couvreur P, Marino JP, Boutan-Laroze A, Rougier P et al. Phase I clinical trial and pharmacokinetic evaluation of doxorubicin carried by polyisohexylcyanoacrylate nanoparticles. Invest New Drugs 1992;10:191–199.
   PubMed Web of Science ®Google Scholar
• Zhou Q, Sun X, Zeng L, Liu J, Zhang Z. A randomized multicenter phase II clinical trial of mitoxantrone-loaded nanoparticles in the treatment of 108 patients with unresected hepatocellular carcinoma. Nanomedicine 2009;5:419–423.
   PubMed Web of Science ®Google Scholar
• Martindale, The complete drug reference, Thirty-Second Edition, Taunton, Massachusetts, USA, 1999:1396–1397.
   Google Scholar
• The United States Pharmacopeia/The National Formulary, USP 31/NF 26, Twinbrook Parkway, Rockville, MD 20852, USA, 2008:3006–3007.
   Google Scholar
• Pignatello R, Bucolo C, Spedalieri G, Maltese A, Puglisi G. Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application. Biomaterials 2002;23:3247–3255.
   PubMed Web of Science ®Google Scholar
• Castelli F, Messina C, Sarpietro MG, Pignatello R, Puglisi G. Eudragit as controlled release system for antiinflammatory drugs A comparison between DSC and dialysis experiments. Thermochim Acta 2003;400:227–234.
   Web of Science ®Google Scholar
• European Pharmacopoeia, Sixth Edition, Council of Europe, Strasbourg, 2007;Vol. 2:2682–2684.
   Google Scholar
• British Pharmacopoeia, The Stationery Office, London, 2008;Vol.2:1731–1732.
   Google Scholar
• Zimmer A, Kreuter J. Microspheres and nanoparticles used in ocular drug delivery systems. Adv Drug Deliver Rev 1995;16:61–73.
   Web of Science ®Google Scholar
• Aksungur P, Demirbilek M, Denkbas EB, Vandervoort J, Ludwig A, Unlü N. Development and characterization of Cyclosporine A loaded nanoparticles for ocular drug delivery: Cellular toxicity, uptake, and kinetic studies. J Control Release 2011;151:286–294.
   PubMed Web of Science ®Google Scholar
• Evans R, Napper DH. Steric stabilization I. Kolloid Z Z Polym 1973;251:409–414.
   Google Scholar
• Evans R, Napper DH. Steric stabilization II. Kolloid Z Z Polym 1973;251:329–336.
   Google Scholar
• Overbeek JThG. Recent developments in the understanding of colloid stability. J Colloid Interf Sci 1977;58:408–422.
   Web of Science ®Google Scholar
• Das S, Suresh PK, Desmukh R. Design of Eudragit RL 100 nanoparticles by nanoprecipitation method for ocular drug delivery. Nanomedicine 2010;6:318–323.
   PubMed Web of Science ®Google Scholar
• Gupta H, Aqil M, Khar RK, Ali A, Bhatnagar A, Mittal G. Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery. Nanomedicine 2010;6:324–333.
   PubMed Web of Science ®Google Scholar
• Araújo J, Gonzalez E, Egea MA, Garcia ML, Souto EB. Nanomedicines for ocular NSAIDs: safety on drug delivery. Nanomedicine 2009;5:394–401.
   PubMed Web of Science ®Google Scholar
• Demirel M, Yazan Y. Katı lipid nanopartiküller (SLN). FABAD 2000;25:167–179.
   Google Scholar
• Basaran E, Demirel M, Sirmagül B, Yazan Y. Polymeric cyclosporine-A nanoparticles for ocular application. J Biomed Nanotechnol 2011;7:714–723.
   PubMed Web of Science ®Google Scholar
• Basaran E, Demirel M, Sirmagül B, Yazan Y. Cyclosporine-A incorporated cationic solid lipid nanoparticles for ocular delivery. J Microencapsul 2010;27:37–47.
   PubMed Web of Science ®Google Scholar
• Lopedota A, Trapani A, Cutrignelli A, Chiarantini L, Pantucci E, Curci R et al. The use of Eudragit RS 100/cyclodextrin nanoparticles for the transmucosal administration of glutathione. Eur J Pharm Biopharm 2009;72:509–520.
   PubMed Web of Science ®Google Scholar
• Chung PH, Chin TF, Lach JL. Kinetics of the hydrolysis of pilocarpine in aqueous solution. J Pharm Sci 1970;59:1300–1306.
   PubMed Web of Science ®Google Scholar